Meeting Coverage
WCN
World Congress of Neurology
VIENNA -- Pooled phase III study results on eslicarbazepine acetate, a prodrug for S(+)-liscarbazepine, showed that the drug outperformed placebo as add-on therapy for partial-onset seizures in adults, a researcher said here.
Latest WCN Meeting Coverage
Latest Neurology Meeting Coverage
-
AANEM: American Association of Neuromuscular & Electrodiagnostic Medicine
October 2024
-
ECTRIMS: European Committee for Treatment and Research in Multiple Sclerosis
September 2024
-
AAN: American Academy of Neurology
April 2024
-
ACTRIMS: Americas Committee for Treatment and Research in Multiple Sclerosis
March 2024